---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-026632"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2022-12-16T23:59:59+00:00"
generated_at: "2026-06-21T03:50:32.053715+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Pediatrix appoints Dr. James Swift as CEO; Mark Ordan becomes Executive Chair

## Summary
- James D. Swift, M.D., named CEO effective Jan 1, 2023; succeeds Mark S. Ordan.
- Mark Ordan appointed Executive Chair of the Board; Guy Sansone becomes Lead Independent Director.
- Swift's base salary increased to $650,000; annual bonus opportunity set at 125% of base.
- Ordan to receive $60,000 monthly fee as Executive Chair through June 30, 2023.
- Swift, a physician and former COO, joined Pediatrix in 2009 through an acquisition.

## SEC filing metadata
- accession: 0000950170-22-026632
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2022-12-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000095017022026632/0000950170-22-026632-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000095017022026632/md-20221215.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-026632
- JSON: https://secwatch.observer/filing/0000950170-22-026632.json
- Plain text: https://secwatch.observer/filing/0000950170-22-026632.txt

## Key facts
- Executive change
  Mark S. Ordan was appointed as Executive Chair of the Board at Pediatrix Medical Group, Inc..
  - Action: appointed
  - Role: Executive Chair of the Board
  source text: Mr. Mark S. Ordan, who has been appointed as the Executive Chair of the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/893949/000095017022026632/0000950170-22-026632-index.htm
- Executive change
  James D. Swift, M.D. was appointed as Chief Executive Officer at Pediatrix Medical Group, Inc..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: appointed James D. Swift, M.D., as the Company’s Chief Executive Officer and principal executive officer to succeed Mr. Mark S. Ordan
  evidence_url: https://www.sec.gov/Archives/edgar/data/893949/000095017022026632/0000950170-22-026632-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.